Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.970101
-0.0549 (-5.36%)
Jul 28, 2026, 1:32 PM EDT - Market open
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,428,944
Market Cap
1.74M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2024 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2023 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2022 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2021 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 26 |
| GeoVax Labs | 19 |
| VivoSim Labs | 15 |
| Azitra | 13 |
| Decoy Therapeutics | 11 |
| CDT Equity | 4 |
| GRI Bio | 4 |
BBLG News
- 5 days ago - Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities - GlobeNewsWire
- 10 days ago - Bone Biologics files to sell 6.46M shares of common stock for holders - TheFly
- 20 days ago - Bone Biologics prices $9.0M offering at $1.42 per share. - TheFly
- 20 days ago - Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - Bone Biologics achieves 29-month shelf life for rhNELL-1 - TheFly
- 2 months ago - Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1 - GlobeNewsWire
- 7 months ago - Bone Biologics summarizes key milestones achieved during 2025 - TheFly
- 7 months ago - Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook - GlobeNewsWire